ArticleEndocrine2019
Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide.
Genya Aharon-Hananel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it